About Alkem Laboratories Ltd
Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical products.
Founded
1973
CEO
Basudeo N Singh
Employees
22,833
HQ
Mumbai, India
Finished Products
1Sales
₹41,706.34Cr2Budgetary Support Benefit
₹367.23Cr3Export Incentives
₹148.27Cr4Other Operating Revenue
₹121.54Cr5Government Subsidy Income
₹70.90Cr6Scrap Sales
₹69.50Cr7Others
₹30.61Cr1–7 of 10
Raw Materials
1Raw Material Consumed
₹9,873.04Cr2Purchase of Traded Goods
₹3,022.30Cr3Packing Materials
₹551.89CrAbout Alkem Laboratories Ltd
Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical products.
Founded:1973
CEO:Basudeo N Singh
Employees:22,833
HQ:Mumbai, India
Finished Products
1Sales
₹41,706.34Cr2Budgetary Support Benefit
₹367.23Cr3Export Incentives
₹148.27Cr4Other Operating Revenue
₹121.54Cr5Government Subsidy Income
₹70.90Cr6Scrap Sales
₹69.50Cr7Others
₹30.61Cr1–7 of 10
Raw Materials
1Raw Material Consumed
₹9,873.04Cr2Purchase of Traded Goods
₹3,022.30Cr3Packing Materials
₹551.89CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹5,934
52W Low
₹5,075
Volume218.22K
Avg VolumeN/A
Beta0.68
Dividend Yield1.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
28.75x
Valuation
P/B Ratio
4.59x
Valuation
EPS
₹184.35
Valuation
Dividend Yield
1.00%
Valuation
ROE
16.66%
Profitability
ROCE
18.61%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharma Business
+33.3%100.0%
₹4,991.54 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
67.8%
International
32.2%
India67.8%
USA20.1%
Other Countries12.1%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.15x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
5.1%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.